KA Imaging’s Reveal™ 35C has been included in the World Health Organization’s (WHO) compendium of innovative health technologies for low-resource settings, launched August 31, 2021.
This compilation features emerging technologies assessed and found to potentially improve health outcomes, the quality of life, or offer a solution to unmet medical needs. The WHO performs technical, wellbutrin and bupropion health technology, regulatory system, quality system, management, and safe use assessments.
The information provided is manufacturer-reported and meant to inform professionals in the medical field about the advantages and challenges involved with implementing innovative health technologies in low-resource settings.
This fifth edition of the compendium prioritizes the need for COVID-19 response and other current health issues.
Reveal 35C is the world’s first portable dual-energy X-ray detector. It has both USA FDA 510(k) clearance and a Health Canada Medical Device Licence. It is currently being used at two clinical sites in Canada, with promising early results. The application for use screening COVID-19 pneumonia is of particular significance now.
About KA Imaging:
A spin-off from the University of Waterloo, KA Imaging specializes in developing innovative X-ray imaging technologies and systems, providing solutions to the medical, veterinary, and non-destructive test industrial markets. For more information, visit www.kaimaging.com.